Exploring the Use of mRNA-LNP for Antigen-Specific Immune Tolerance

Time: 9:00 am
day: Conference Day Two


  • Focusing on the mRNA and LNP to identify an optimal drug product for inducing antigen-specific tolerance
  • Highlighting the influence of the antigen on T-cell fate outcomes
  • Interrogating what target product profile may be achievable